Co-infected Hepatitis C Patients Find New Options, New Obstacles
Patients co-infected with hepatitis C and HIV may have newfound hope. Clinical trial results presented at the 2015 Conference on Retroviruses and Opportunistic Infections show that a new combination pill worked for co-infected patients of certain genotypes 96 percent of the time.
Spikes in RSV Rekindle Access Worries
As the season for respiratory syncytial virus (RSV) wages on, several states have reported alarming rates of the virus.
One-Size-Fits-All Cancer Care? Oncology Consolidation and Patient Access
Increasingly, I see cancer care shifting from private or small, community-based practices to larger practices or more urban hospital centers.
Rare Disease Day Spurs Awareness
As Rare Disease Day nears, patients, their families and the organizations that represent them are fighting for greater awareness of the conditions they face.
AfPA Welcomes the National Premature Infant Health Coalition
This month the Alliance for Patient Access takes on a new project dedicated to health care access for infants, the National Premature Infant Health Coalition.
Exchange Open Enrollment Ends, But Rx Access Concerns Linger
Open enrollment at HealthCare.gov ended February 15, initiating the program’s second year of offering health insurance to Americans.
States Debate Rules for Biosimilar Swaps
First filgrastim, now infliximab.
Will America’s $133M Opioid Abuse Solution Overlook Patients?
President Obama’s 2016 fiscal year budget throws big money at one of America’s biggest public health challenges: opioid abuse.
Exchange Plans’ Cost-sharing Confuses, Burdens Patients
Patients with federal exchange health care plans may not fully understand the extent of their out-of-pocket cost obligations, a new study shows.
Europe and Australia Reshuffle on Generics, Biosimilars
Europe and Australia are reassessing, recalling and reflecting on biosimilars and generic medications.
